Allan Steven Jacobson, Director at PTC THERAPEUTICS, INC. (PTCT), sold 51,600 shares at $80.13 ($4.2M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($4.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.13 | 5,701 | $457K | 10.8% |
| 2 | $80.13 | 5,701 | $457K | 10.8% |
| 3 | $80.15 | 6,100 | $489K | 11.6% |
| 4 | $80.15 | 6,100 | $489K | 11.6% |
| 5 | $82.58 | 2,460 | $203K | 4.8% |
| 6 | $82.58 | 2,460 |
| $203K |
| 4.8% |
| 7 | $82.63 | 2,264 | $187K | 4.4% |
| 8 | $82.63 | 2,264 | $187K | 4.4% |
| 9 | $83.38 | 3,502 | $292K | 6.9% |
| 10 | $83.38 | 3,502 | $292K | 6.9% |
| 11 | $83.93 | 2,510 | $211K | 5.0% |
| 12 | $83.93 | 2,510 | $211K | 5.0% |
| 13 | $84.45 | 1,125 | $95K | 2.2% |
| 14 | $84.45 | 1,125 | $95K | 2.2% |
| 15 | $84.47 | 1,238 | $105K | 2.5% |
| 16 | $84.47 | 1,238 | $105K | 2.5% |
| 17 | $85.24 | 400 | $34K | 0.8% |
| 18 | $85.32 | 700 | $60K | 1.4% |
| 19 | $85.32 | 700 | $60K | 1.4% |
| Total | $81.98 avg | 51,600 | $4.2M | 100% |
| Filing → |
| PTCT | SELL | 2025-03-06 | $127K | — | Filing → |
| PTCT | SELL | 2024-01-24 | $274K | — | Filing → |
| PTCT | SELL | 2023-05-12 | $2.3M | — | Filing → |